Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations-Reference-Cited by-同舟云学术

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

Published:2019-04-03 Issue:1 Volume:16 Page:
ISSN:1477-7517
Container-title:Harm Reduction Journal
language:en
Short-container-title:Harm Reduct J

Author:

Neale Joanne^ORCID,Tompkins Charlotte N. E.,Strang John

Funder

Camurus Lipid Research Foundation

Pilgrim Trust

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s12954-019-0296-4.pdf

Reference27 articles.

1. Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother. 2009;10:1727–40.

2. SAMHSA (Substance Abuse and Mental Health Services Administration). Medications to treat opioid use disorder. Treatment improvement protocol (TIP) series 63, full document. HHS publication no. (SMA) 18-5063FULLDOC. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.

3. European Medicines Agency. Buvidal®. https://www.ema.europa.eu/en/medicines/human/EPAR/buvidal (2018). Accessed 23 Dec 2018.

4. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(Suppl 2):S13–27.

5. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04–3939. Rockville: Substance Abuse and Mental Health Services Administration; 2004.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study;Journal of Substance Use and Addiction Treatment;2024-08

2. Provider Perceptions toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder;Journal of Addiction Medicine;2024-06-03

3. Beginning with buprenorphine depot: characteristics and experiences of the first patients in a French addiction centre;Heroin Addiction and Related Clinical Problems;2024-03

4. Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA;Drugs & Therapy Perspectives;2024-02

5. Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis;Journal of Substance Use and Addiction Treatment;2023-11